Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth P Lerner

Showing results (91-100 of 294) with videos related to

Pageof 30
Sort By:
The Journal of Urology|September 8, 2015
External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical CystectomyMichael Brooks, Guilherme Godoy, Maxine Sun, et al.
The Journal of Urology|January 25, 2003
Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer riskHua Zhao, H Barton Grossman, Margaret R Spitz, et al.
Urologic Oncology|June 7, 2008
Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical modelGuru Sonpavde, Weiguo Jian, Hao Liu, et al.
Urology|December 8, 2009
Bladder cancer detection, treatment and outcomes: opportunities and challengesDavid M Latini, Seth P Lerner, Sally W Wade, et al.
The American Journal of Clinical Nutrition|March 13, 2018
Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort studyHuakang Tu, Colin P Dinney, Yuanqing Ye, et al.
Human Pathology|May 31, 2006
Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significanceSteven S Shen, Seth P Lerner, Bahar Muezzinoglu, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2021
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinomaAhmad Shabsigh, Nir Kleinmann, Angela B Smith, et al.
The Journal of Urology|November 25, 2003
Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomyKazumasa Matsumoto, Shahrokh F Shariat, Roberto Casella, et al.
Journal of Clinical Urology|November 8, 2016
Transurethral biopsy of the prostatic urethra is associated with final apical margin status at radical cystoprostatectomyFriedrich-Carl von Rundstedt, Douglas A Mata, Steven Shen, et al.
Urology|February 25, 2003
Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancerShahrokh F Shariat, JaHong Kim, Cuong Nguyen, et al.
Pageof 30

Showing results (91-100 of 294) with videos related to

Sort By:
Pageof 30
The Journal of Urology|September 8, 2015
External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical CystectomyMichael Brooks, Guilherme Godoy, Maxine Sun, et al.
The Journal of Urology|January 25, 2003
Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer riskHua Zhao, H Barton Grossman, Margaret R Spitz, et al.
Urologic Oncology|June 7, 2008
Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical modelGuru Sonpavde, Weiguo Jian, Hao Liu, et al.
Urology|December 8, 2009
Bladder cancer detection, treatment and outcomes: opportunities and challengesDavid M Latini, Seth P Lerner, Sally W Wade, et al.
The American Journal of Clinical Nutrition|March 13, 2018
Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort studyHuakang Tu, Colin P Dinney, Yuanqing Ye, et al.
Human Pathology|May 31, 2006
Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significanceSteven S Shen, Seth P Lerner, Bahar Muezzinoglu, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2021
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinomaAhmad Shabsigh, Nir Kleinmann, Angela B Smith, et al.
The Journal of Urology|November 25, 2003
Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomyKazumasa Matsumoto, Shahrokh F Shariat, Roberto Casella, et al.
Journal of Clinical Urology|November 8, 2016
Transurethral biopsy of the prostatic urethra is associated with final apical margin status at radical cystoprostatectomyFriedrich-Carl von Rundstedt, Douglas A Mata, Steven Shen, et al.
Urology|February 25, 2003
Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancerShahrokh F Shariat, JaHong Kim, Cuong Nguyen, et al.
Pageof 30